Other languages Bristol-Myers Squibb Company

Equities

BMY

US1101221083

Market Closed - Nyse Other stock markets 21:00:02 01/05/2024 BST			5-day change	1st Jan Change
44.21 ^USD	+0.61%		-9.52%	-13.84%

05-01	HSBC Adjusts Price Target on Bristol-Myers Squibb to $45 From $50	MT
05-01	Editas Medicine, Bristol-Myers Squibb Extend Alpha-Beta T Cell Collaboration	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Malgré un fort recul lié aux soins anti-Covid, Pfizer relève ses prévisions	05-01
RECOMENDACIONES DE LOS ANALISTAS EE.UU./UK : Tesla, Snap, Alphabet, Microsoft, Anglo American...	04-30
Scenic Biotech Enters into Research Collaboration with Bristol Myers Squibb	04-30
Japan's Ono Pharma says $2.4 bln Deciphera purchase 'first step' for global expansion	04-30
Après Microsoft, Alphabet, Tesla et Apple, Amazon doit faire le job	04-30
En Direct des Marchés : Thales, Stellantis, Capgemini, Atos, VusionGroup, Orpea, Adidas, HSBC...	04-30
Borsa di Italia: Dopo Microsoft, Alphabet, Tesla e Apple, Amazon deve fare il suo lavoro	04-30
IN DIRETTA DAI MERCATI: Tenaris, Generali, Caixabank, Eni, Leonardo, Stellantis, HSBC, Webuild, Samsung, Coca-Cola, Tesla, Caterpillar...	04-30
EN DIRECTO DESDE LOS MERCADOS: BBVA, Santander, Caixabank, Soltec, Ercros, Grifols, HSBC, Samsung, Coca-Cola, Tesla, Caterpillar...	04-30
Bolsa de Madrid: Tras Microsoft, Alphabet, Tesla y Apple, Amazon debe hacer su trabajo	04-30
J&J, Bristol Myers lose challenges to US drug price negotiation program	04-29
Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases	04-29
S&P 500 Q1 earnings estimated growth improves; stocks up for week	04-26
Bristol-Myers Squibb Says European Regulator Recommends Approval of Bladder Cancer Combination Therapy	04-26
Bristol Myers : avis favorable du CMHP pour Opdivo	04-26
CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb's Opdivo in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma	04-26
Sector Update: Health Care Stocks Decline Late Afternoon	04-25
Sector Update: Health Care Stocks Drop in Afternoon Trading	04-25
Sector Update: Health Care	04-25
Bristol-Myers Squibb Swings to Q1 Non-GAAP Loss, Revenue Rises; Provides 2024 Guidance -- Shares Fall	04-25

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Christopher Boerner, CEO of Bristol-Myers: A pipeline of 16 treatments, with a focus on neuroscience and oncology

January 09, 2024 at 06:06 pm